Caricamento...
MET targeted therapy for lung cancer: clinical development and future directions
MET, the receptor for hepatocyte growth factor, has been identified as a novel promising target in various human malignancies, including lung cancer. Research studies have demonstrated that MET signaling plays important physiologic roles in embryogenesis and early development, whereas its deregulati...
Salvato in:
| Pubblicato in: | Lung Cancer (Auckl) |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312490/ https://ncbi.nlm.nih.gov/pubmed/28210125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S23423 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|